Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 318
Healthy volunteers: no

Brief summary:
Assess the efficacy \& tolerability of Vyvanse when children aged 6-12 years diagnosed with ADHD are dosed to optimal effect.

Detailed description:
Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (lisdexamfetamine dimesylate) in Children aged 6-12 Diagnosed with ADHD

Arms:
arm 1: None

Interventions: intervention 1: Vyvanse (lisdexamfetamine dimesylate)
Intervention descriptions: intervention 1: Vyvanse™ 20mg once daily at 7 a.m.; dose increased weekly by 10mg until an acceptable response is achieved. Titration may proceed to a maximum daily dose 70mg/day.

Protocol document: